Izotropic Corporation is a pioneering brand that specializes in the development and commercialization of a dedicated Breast CT platform. Their mission is to enable earlier detection, diagnosis, and treatment of breast cancers, ultimately saving lives. With a team of renowned experts in the field, including Dr.

John Boone, principal founder of Breast CT, and Dr. Younes Achkire, chief operating officer, Izotropic Corporation brings together a wealth of experience and expertise. They are supported by an exceptional management team, including interim CEO Robert Thast, who has a strong track record of success in the industry.

Izotropic Corporation offers a range of products and services to support their mission. Their innovative IzoView Breast CT device is at the forefront of breast imaging technology, providing accurate and detailed insights for healthcare professionals. The company also collaborates with leading institutions, such as Johns Hopkins University School of Medicine, to develop deep machine learning algorithms for their platform.

Investors can be confident in Izotropic Corporation's commitment to excellence and their dedication to advancing breast imaging technology. With their cutting-edge solutions, they are revolutionizing the field and empowering healthcare providers to make more informed decisions in the fight against breast cancer